Throat Lozenges Market to grow at a CAGR of 4.92% during 2025 to 2035; Driven by Rising Prevalence of Throat Infections and Increasing Demand for Over-the-Counter Symptomatic Relief Products

According to a detailed study by Market Research Future (MRFR), the Global Throat Lozenges Market size was valued at USD 4.93 billion in 2024 and is projected to grow from USD 5.17 billion in 2025 to USD 8.36 billion by 2035, registering a compound annual growth rate (CAGR) of 4.92% during the forecast period (2025–2035).

The key players recognized by MRFR operating in the Throat Lozenges Market include global healthcare leaders such as Reckitt Benckiser (GB), Procter & Gamble (US), Pfizer (US), Bayer (DE), and GlaxoSmithKline (GB). The market is also supported by prominent industry participants, including Haleon (GB), Church & Dwight (US), and MediNatura (DE).

Market Highlights

The Throat Lozenges Market is currently undergoing dynamic evolution, driven by increasing awareness of throat health, rising incidence of respiratory conditions, and a strong consumer shift toward self-care and over-the-counter remedies. Upper respiratory infections continue to affect hundreds of millions of people annually, creating sustained demand for convenient, symptomatic relief solutions.

Key growth drivers include expanding retail and e-commerce channels, seasonal demand surges during colder months, heightened self-care practices, product formulation innovations, and the rising prevalence of throat disorders. Global internet penetration exceeding 68% has accelerated online sales of healthcare products, which are growing at over 8% annually. Additionally, PubMed research indicates that over 70% of adults use over-the-counter products to manage common minor ailments, while over 60% of global consumers now prefer natural or plant-based remedies containing ingredients such as honey, ginger, and menthol.

Regulatory frameworks and body guidelines across major regions continue to foster product safety, quality, and clinical innovation. Health authorities such as the FDA in North America and the European Medicines Agency (EMA) support streamlined approval processes for over-the-counter products, encouraging manufacturers to introduce sugar-free, organic, and multifunctional lozenge formulations to the global market.

Segment Analysis

The Global Throat Lozenges Market is segmented by type, ingredient, indication, and region.

By type, the market is segmented into Hard Candy Lozenges, Soft Lozenges, and Compressed Lozenges. The Hard Candy Lozenges segment dominates the market, accounting for a significant 58% share in 2024 due to long-standing consumer familiarity, proven effectiveness, and broad retail availability. Meanwhile, Soft Lozenges represent the fastest-growing segment, rapidly gaining traction among health-conscious consumers seeking alternative formats.

Based on ingredient, the market is divided into Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey & Ginger, Lemon, and Others. Menthol-based formulations hold the largest share, accounting for nearly 46% of ingredient segment revenue in 2024, driven by widespread therapeutic acceptance and soothing properties. Honey & Ginger represents the fastest-growing segment, appealing strongly to consumers seeking natural and herbal throat care remedies.

By indication, the market is segmented into Sore Throat, Cough and Cold, and Throat Diseases. Sore Throat applications dominate the segment, accounting for approximately 55% of market demand in 2024, driven by the high prevalence of throat irritation. Cough and Cold represents the fastest-growing segment, driven by increasing consumer demand for multi-symptom relief solutions during seasonal illness peaks.

Regional Analysis

Regionally, the Global Throat Lozenges Market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa.

North America leads the global market, accounting for over 40.57% of the market share and generating around USD 2 billion in revenue in 2024. Sustained demand in the US and Canada is driven by high rates of upper respiratory physician visits, strong health awareness, and FDA regulatory support.

Europe generated USD 1.48 billion in revenue during 2024, representing the second-largest share at 30.02%. Market expansion in Germany and the UK is supported by an aging population, robust e-commerce distribution, and European Medicines Agency regulatory standards.

Asia-Pacific is the fastest-growing regional market, accounting for approximately 25% of global revenue. Growth in China and India is fueled by rising disposable incomes, expanding internet infrastructure, and strong consumer preference for herbal and natural lozenge formulations.

Middle East and Africa hold approximately 5% of the global market share as an emerging region. Market growth in South Africa and the UAE is driven by expanding urban populations, increasing healthcare expenditure, and rising availability across retail channels.

Key Findings of the Study

• The Global Throat Lozenges Market size was valued at USD 4.93 billion in 2024 and is projected to reach USD 8.362 billion by 2035, growing at a 4.92% CAGR from 2025 to 2035.


• Hard Candy Lozenges capture the largest market share by type (58% in 2024), while Soft Lozenges represent the fastest-growing segment.


• Menthol constitutes the largest ingredient segment (46% revenue share in 2024), with Honey & Ginger highlighted as the fastest-growing formulation.


• Sore Throat relief is the largest indication segment (55% of market demand in 2024), while Cough and Cold is the fastest-growing indication.


• North America dominates the global market with a 40.57% share, while Asia-Pacific is projected to be the fastest-growing regional market.


• Key market participants include Reckitt Benckiser, Procter & Gamble, Pfizer, Bayer, GlaxoSmithKline, Haleon, Church & Dwight, and MediNatura.